Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States

Annals of Epidemiology

Volumn 16, Issue 4, 2006, Pages 305-312

  Miller, Thaddeus L ^a,b   Hilsenrath, Peter ^a,b   Lykens, Kristine ^a,b   Mcnabb, Scott J N ^c   Moonan, Patrick K ^a,b   Weis, Stephen E ^a,b,d  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNT Health Sciences Center   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Tarrant County Public Health Department   (United States)

Author keywords

Evaluation; Health Economics; Prevention; Public Health; Targeted Testing; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; FEMALE; HEALTH PROGRAM; HOMELESSNESS; HUMAN; INCIDENCE; LAW; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PRISON; PRODUCTIVITY; RETROSPECTIVE STUDY; SCREENING; SHORT COURSE THERAPY; TUBERCULOSIS; UNITED STATES;

COSTS AND COST ANALYSIS; HEALTH PRIORITIES; HEALTH SERVICES NEEDS AND DEMAND; HOMELESS PERSONS; HUMANS; MASS SCREENING; PRISONERS; TEXAS; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 33644946450     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2005.07.053     Document Type: Article

References (76)

1. Walker DM. Health Care System Crisis: Growing Challenges Point to Need for Fundamental Reform. Government Accountability Office. Available at: http://www.gao.gov/cghome/hccrisis/. Accessed November 20, 2004.
2. M.R. Gillick Medicare coverage for technological innovations-time for new criteria? N Engl J Med 350 2004 2199 2203
3. L.B. Russell, M.R. Gold, J.E. Siegel, N. Daniels, and M.C. Weinstein The role of cost-effectiveness analysis in health and medicine JAMA 276 1996 1172 1177
4. S.R. Tunis Why Medicare has not established criteria for coverage decisions N Engl J Med 350 2004 2196 2198
5. Centers for Disease Control and Prevention Reported Tuberculosis in the United States, 2003 2004 CDC Atlanta, GA
6. Centers for Disease Control and Prevention. Fact Sheet: Tuberculosis in the United States, 2004. Available at: http://www.cdc.gov/od/oc/media/pressrel/ fs050317.htm. Accessed June 22, 2005.
7. Centers for Disease Control and Prevention Tuberculosis morbidity among U.S.-born and foreign-born populations - 2000 MMWR Morbid Mortal Wkly Rep 51 2002 101 104
8. Centers for Disease Control and Prevention Tuberculosis elimination revisited: Obstacles, opportunities, and a renewed commitment MMWR Morbid Mortal Wkly Rep 48 1999 No. RR-9:1-13
9. Martin K. Tarrant County Community Development Division, personal communication. December 14, 2004.
10. 2000 US Census American Community Survey, 2002. Available at: www.census.gov. Accessed February 1, 2004.
11. Henry J. Kaiser Foundation. 2400 Sand Hill Road, Menlo Park, CA. Long-Term Care: Medicaid's Role and Challenges. Publication no. 2172. Henry J. Kaiser Foundation; 1999.
12. US Department of Justice, Office of Justice Programs. Prison and Jail Inmates at Midyear, 2002. Bureau of Justice Statistics Bulletin, April 2003. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/pjim02.pdf. Accessed January 11, 2005.
13. US Census Bureau. Foreign-Born Population of the United States Current Population Survey - March 2002 Detailed Tables (PPL-162). Available at: www.census.gov/prod/2003pubs/p20-539.pdf. Accessed February 26, 2004.
14. Institute of Medicine Ending Neglect: The Elimination of Tuberculosis in the United States 2000 National Academy Washington, DC
15. Wilcock K, Hammett TM, Widom R, Epstein J. Tuberculosis in Correctional Facilities, 1994-1995. National Institute of Justice Research in Brief, US Department of Justice, Office of Justice Programs; US Department of Justice, Washington, DC 1996.
16. Hammett TM, Harmon P, Maruschak LM. 1996-1997 Update: HIV/AIDS, STDs, and TB in Correctional Facilities. US Department of Justice, Office of Justice Programs; US Department of Justice, Washington, DC 1999.
17. T.F. Brewer, S.J. Heymann, S.M. Krumplitsch, M.E. Wilson, G.A. Colditz, and H.V. Fineberg Strategies to decrease tuberculosis in US homeless populations: A computer simulation model JAMA 286 2001 834 842
18. P.K. Moonan, M. Bayona, T.N. Quitugua, J. Oppong, D. Dunbar, and K.C. Jost Jr. Using GIS technology to identify areas of tuberculosis transmission and incidence Int J Health Geographics 3 2004 23 33
19. N.J. Rendleman Mandated tuberculosis screening in a community of homeless people Am J Prev Med 17 1999 108 113
20. Centers for Disease Control and Prevention Prevention and Control of Tuberculosis in Correctional Facilities 1995 CDC Atlanta, GA
21. Centers for Disease Control and Prevention Screening for tuberculosis and tuberculosis infection in high risk populations: Recommendations of the Advisory Council for the Elimination of Tuberculosis MMWR Morbid Mortal Wkly Rep 44 1994 19 34
22. C.R. Horsburgh Jr. Priorities for the treatment of latent tuberculosis infection in the United States N Engl J Med 350 2004 2060 2067
23. Centers for Disease Control and Prevention Targeted tuberculin testing and treatment of latent tuberculosis infection MMWR Morbid Mortal Wkly Rep 49 No. RR-6 2000 1 54
24. Centers for Disease Control and prevention Prevention and control of tuberculosis in US communities with at-risk minority populations: Recommendations of the Advisory Council for the Elimination of Tuberculosis and Prevention and control of tuberculosis among homeless persons: Recommendations of the Advisory Council for the Elimination of Tuberculosis MMWR Morbid Mortal Wkly Rep 41 RR-5 1992 1 11
25. Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis MMWR Morbid Mortal Wkly Rep 44 1995 1 16
26. Texas Health and Safety Code, Title 25, Part I, Chapter 97, Sub-Chapter H. Available at: http://info.sos.state.tx.us/pls/pub/readtac$ext.ViewTAC? tac_view = 5&ti = 25&pt = 1&ch = 97&sch = H&rl = Y. Accessed December 1, 2004.
27. L. King, and G. Geis Tuberculosis transmission in a large urban jail JAMA 237 1977 791 792
28. T.F. Jones, and W. Schaffner Miniature chest radiograph screening for tuberculosis in jails: A cost-effectiveness analysis Am J Respir Crit Care Med 164 2001 77 81
29. M.N. Lobato, C.A. Roberts, L.B. Bazerman, and T.M. Hammett Public health and correctional collaboration in tuberculosis control Am J Prev Med 27 2004 112 117
30. T.M. Hammett, M.P. Harmon, and W. Rhodes The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997 Am J Public Health 92 2002 1789 1794
31. M.C. White, J.P. Tulsky, C.J. Portillo, E. Menendez, E. Cruz, and J. Goldenson Tuberculosis prevalence in an urban jail: 1994 and 1998 Int J Tuberc Lung Dis 5 2001 400 404
32. J.P. Tulsky, M.C. White, C. Dawson, T.M. Hoynes, J. Goldenson, and G. Schecter Screening for tuberculosis in jail and clinic follow-up after release Am J Public Health 88 1998 223 226
33. M.C. White, J.P. Tulsky, P. Reilly, H.W. MacIntosh, T.M. Hoynes, and J. Goldenson A clinical trial of financial incentive to go to the tuberculosis clinic for isoniazid preventive therapy for released jail inmates Int J Tuberc Lung Dis 2 1998 506 512
34. T. Lincoln, G.L. Brannan, V. Lynch, T.J. Conklin, T. Clancey, and T.N. Rose Completing tuberculosis prophylaxis in jail: Targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens Int J Tuberc Lung Dis 8 2004 306 311
35. L.B. Reichman On target. A tuberculosis control strategy whose time has come Ann Intern Med 131 1999 617 618
36. T.F. Jones, A.S. Craig, S.E. Valway, C.L. Woodley, and W. Schaffner Transmission of tuberculosis in jails Ann Intern Med 131 1999 557 563
37. US Census Bureau. US Census, 2000. Available at: http://quickfacts. census.gov/qfd/states/48/48439.html. Accessed February 1, 2004.
38. Centers for Disease Control and Prevention. Self Study Modules on Tuberculosis 1-5, Course #SS3035. National Center for HIV, STD, and TB Prevention, Division of Tuberculosis Elimination. Available at: http://www.phppo.cdc.gov/PHTN/tbmodules/Default.htm. Accessed December 20, 2004.
39. Moonan PK, Bayona M, Quitugua TN, Oppong J, Burgess G, Hines NL, et al. Targeted Screening for Tuberculosis Combining GIS and Genotyping Technology. Presented at American Public Health Association Annual Meeting, San Francisco, CA, November 15, 2003.
40. Qualls N. Centers for Disease control and prevention, personal communication. December 14, 2004.
41. US Department of Labor. Bureau of Labor Statistics Occupational Employment Statistics, May 2003. Available at: http://www.bls.gov/oes/2003/may/ oes211091.htm#nat. Accessed November 22, 2004.
42. US Department of Labor. Bureau of Labor Statistics. Consumer Price Index Urban Wage Earners and Clerical Workers, Medical Care US City Average. Available at: http://data.bls.gov/cgi-bin/surveymost. Accessed November 22, 2004.
43. Centers for Disease Control and Prevention Treatment of tuberculosis MMWR Morbid Mortal Wkly Rep 52 2003 1 88
44. US Department of Labor. Bureau of Labor Statistics. CPI Urban Wage Earners and Clerical Workers, Medical Care Services US City Average. Available at: http://data.bls.gov/cgi-bin/surveymost. Accessed November 22, 2004.
45. US Department of Labor, Bureau of Labor Statistics. CPI for Medical Care Commodities. Available at: http://www.bls.gov/news.release/cpi.t05.htm. Accessed November 22, 2004.
46. Z. Taylor, S.M. Marks, N.M. Rios Burrows, S.E. Weis, R.L. Stricof, and B. Miller Causes and costs of hospitalization of tuberculosis patients in the United States Int J Tuberc Lung Dis 4 2000 931 939
47. F. Gordin, R.E. Chaisson, J.P. Matts, C. Miller, M. de Lourdes Garcia, and R. Hafner Rifampin and pyrazinimide vs. isoniazid for prevention of tuberculosis in HIV-infected persons: An international randomized trial JAMA 283 2000 1445 1450
48. IUAT Committee on Prophylaxis Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial Bull World Health Org 60 44 1982 555 564
49. S.H.E. Ferebee Controlled chemoprophylaxis trials in tuberculosis: A general review Adv Tuberc Res 17 1970 28 106
50. G.W. Comstock How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 10 1999 847 850
51. H.S. Javitz, and M. Ward Value of antimicrobials in the prevention and treatment of tuberculosis in the United States Int J Tuberc Lung Dis 6 2002 275 288
52. Z. Taylor The cost-effectiveness of screening for latent tuberculosis infection Int J Tuberc Lung Dis 4 suppl 2000 S127 S133
53. E.E. Salpeter, and S.R. Salpeter A mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function Am J Epidemiol 47 1998 398 406
54. D.C. Snyder, A.E. Paz, J.C. Moehle-Boetani, R. Fallstad, R.L. Black, and D.P. Chin Tuberculosis prevention in methadone maintenance clinics: Effectiveness and cost-effectiveness Am J Respir Crit Care Med 160 1999 178 185
55. D.C. Snyder, and D. Chin Cost-effectiveness analysis of directly observed therapy for patients with tuberculosis at low risk for treatment default Am J Respir Crit Care Med 160 1999 582 586
56. S.R. Salpeter, G.D. Sanders, E.E. Salpeter, and D.K. Owens Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: A risk-benefit and cost-effectiveness analysis Ann Intern Med 127 1997 1051 1061
57. D.N. Rose Benefits of screening for latent Mycobacterium tuberculosis infection Arch Intern Med 160 2000 1513 1521
58. K. Floyd Costs and effectiveness - The impact of economic studies on TB control Tuberculosis 83 2003 187 200
59. N.J. Rendleman Mandated tuberculosis screening in a community of homeless people Am J Prev Med 17 1999 108 113
60. P.F. Barnes, Z. Yang, J.M. Pogoda, S. Preston-Martin, B.E. Jones, and M. Otaya Foci of tuberculosis transmission in central Los Angeles Am J Respir Crit Care Med 159 1999 1081 1086
61. M. Lathan, L. Ntaate Musaka, N. Hooper, J. Golub, N. Baruch, and D. Mucahy Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, DC, 1996-2000, linked to the homeless Emerg Infect Dis 8 2002 1249 1251
62. S. Munsiff, T. Bassoff, B. Nivin, H. Li, A. Sharma, and P. Bifani Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997 Emerg Infect Dis 8 2002 1230 1238
63. Centers for Disease Control and Prevention Public health dispatch: Tuberculosis outbreak among homeless persons - King County, Washington, 2002-2003 MMWR Morbid Mortal Wkly Rep 52 2003 1209 1210
64. N.N. Bock, B.S. Metzger, J.R. Tapia, and H.M. Blumberg A tuberculin screening and isoniazid preventive therapy program in an inner-city population Am J Respir Crit Care Med 159 1999 295 300
65. A.L. French, S.F. Welbel, S.E. Dietrich, L.B. Mosher, P.S. Breall, and W.S. Paul Use of DNA fingerprinting to assess tuberculosis infection control Ann Intern Med 129 1998 856 861
66. Burt ML. What Will It Take to End Homelessness? Urban Institute. 2001. Available at: http://www.urban.org/url.cfm?ID = 310305. Accessed December 1, 2004.
67. P.M. Kong, J. Tapy, and P. Calixto Skin-test screening and tuberculosis transmission among the homeless Emerg Infect Dis 8 2002 1280 1284
68. J.P. Tulsky, L. Pilote, J.A. Hahn, A.J. Zolopa, M. Burke, and M. Chesney Adherence to isoniazid prophylaxis in the homeless: A randomized controlled trial Arch Intern Med 160 2000 697 702
69. W.J. Burman, D.L. Cohn, C.A. Rietmeijer, F.N. Judson, J.A. Sbarbaro, and R.R. Reves Noncompliance with directly-observed therapy for tuberculosis: Epidemiology and effect on the outcome of treatment Chest 111 1997 1168 1173
70. A. Pablos-Méndez, C.A. Knirsch, R.G. Barr, B.H. Lerner, and T.R. Frieden Nonadherence in tuberculosis treatment: Predictors and consequences in New York City Am J Med 102 1997 164 170
71. S.J.N. McNabb, A. Surdo, A. Redmond, J. Cobb, J. Wiley, and S. Chakrabarti Applying a new conceptual framework to evaluate public health surveillance and action, Hillsborough County, Florida, 2002 Ann Epidemiol 14 2004 640 645
72. US Department of Justice, Office of Justice Programs. Bureau of Justice Statistics Profile of Jail Inmates, 2002. Available at: www.ojp.usdoj.gov/bjs/. Accessed December 12, 2004.
73. F. Chaves, M.D. Dronda, M. Cave, A. Alonso-Sanez, and K.D. Gonzalez-Lopez A longitudinal study of transmission of tuberculosis in a large prison population Am J Respir Crit Care Med 155 1997 719 725
74. A.R. Pelletier, G.T. DiFerdinando Jr., A.G. Greenberg, D.M. Sosin, W.D. Jones Jr., and A.B. Bloch Tuberculosis in a correctional facility Arch Intern Med 153 1993 2692 2695
75. S.E. Weis, T.L. Miller, P.E. Hilsenrath, and P.K. Moonan Comprehensive cost description of tuberculosis care Int J Tuberc Lung Dis 9 4 2005 467 470
76. Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection MMWR Morbid Mortal Wkly Rep 52 2003 735 739